<DOC>
	<DOCNO>NCT00827931</DOCNO>
	<brief_summary>Tranexamic acid show reduce postoperative blood loss transfusion requirement various type major surgery ( orthopedic surgery , spine surgery , cardiopulmonary bypass , liver resection , gynecological cancer ) .The current trial conduct compare efficacy tranexamic acid plus standard care versus standard care reduction blood loss patient undergo major abdominal surgery .</brief_summary>
	<brief_title>Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Tranexamic Acid</mesh_term>
	<criteria>Patient undergo major abdominal surgery ( Biliary stricture , Pancreaticoduodenectomy , Esophagectomy , Total proctocolectomy , Hemicolectomy , Gastrectomy , Other major abdominal surgery similar expect blood loss ) Patients platelet count less 100 , 000/mm3 history thrombocytopenia . Patients know coagulopathy . Patients anemia ( hemoglobin level less 8 mg/dl ) Patients document DVT PE screen past three month . Patients associated major illness ( e.g. , severe cardiac respiratory disease ) . Anticoagulants ( LMWH heparin prophylactic dos prevent deep vein thrombosis ) , direct thrombin inhibitor thrombolytic therapy administer complete within last week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>tranexamic acid</keyword>
	<keyword>major abdominal surgery</keyword>
	<keyword>blood loss</keyword>
</DOC>